Have you been diagnosed with Asthma?
Learn about a no-cost investigational treatment that may help to control asthma symptoms.
Do you struggle with mild to moderate asthma?
Asthma is a chronic inflammatory disease that often causes shortness of breath, wheezing, cough, and chest tightness. Despite advances, many patients still need better treatment options to manage their condition and prevent worsening symptoms.
If you have asthma, you may qualify for a clinical research study evaluating an investigational medication designed to reduce asthma exacerbations, improve lung function, and enhance overall asthma control. This medication, administered as a subcutaneous (under the skin) injection every 4 weeks, targets specific pathways that contribute to asthma.
The study is being conducted at select locations across 22 countries, and eligible participants will receive all study-related care at no cost. Compensation for time and travel may also be available.
FILL OUT THE FORM BELOW IF YOU MEET THE FOLLOWING CRITERIA
• Are 18 to 80 years of age
• Have been diagnosed with asthma for at least 12 months
• Are taking daily treatment for asthma
• Have had at least 1 asthma attack in the past year
• Are not pregnant, breastfeeding, or planning to become pregnant
About the Study
This clinical research study evaluates an investigational medication designed to reduce asthma exacerbation rates, improve lung function, and enhance patient-reported outcomes in individuals with mild-to-moderate asthma.
The study will last up to 64 weeks and includes a once-monthly injection under the skin during the treatment period. The investigational medication targets specific pathways in the body that trigger and worsen asthma symptoms. Participants will continue their regular asthma therapy of inhaled corticosteroids (ICS) with or without long-acting beta agonists (LABA) along with the investigational medication.
Participation is at no cost and includes all study-related medical examinations, lung function tests, ECGs, laboratory work, and various evaluations conducted by medical investigators. Additionally, you may receive compensation for the time and travel required to participate.
Why Participate?
If you have asthma, you may qualify for a new clinical research study evaluating an investigational medication designed to reduce asthma exacerbations, ER visits, and hospitalizations, and protect lung function over time.
If you qualify, you will receive:
No-cost Study Care
You will receive study-related care from experienced doctors, nurses, and research staff.
Exams
The study will include physical examinations, lung function tests, ECGs, laboratory work, and other examination visits with a trained investigator.
Compensation
You might be eligible to receive compensation for your time and travel.
Chat With a Research Coordinator
Fill out the form below to determine if you are eligible. If you meet the initial criteria, a research team member from a location near you will contact you. If you don’t qualify now, please still submit the form. The study criteria may change, and you could become eligible then.
© 2025 Accelerate Recruitment | Privacy Policy | Legal Notice
